carmustine has been researched along with Maxillary Neoplasms in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Maxillary Neoplasms: Cancer or tumors of the MAXILLA or upper jaw.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Primack, A | 1 |
| Dhru, D | 1 |
| Kiryabwire, JW | 1 |
| Vogel, CL | 1 |
1 trial available for carmustine and Maxillary Neoplasms
| Article | Year |
|---|---|
Clinical trials of combination chemotherapy with BCNU and vincristine in the treatment of malignant melanoma in Uganda.
Topics: Adult; Aged; Carmustine; Clinical Trials as Topic; Female; Follow-Up Studies; Foot; Humans; Leukocyt | 1973 |